Essential tremor and epilepsy are different treatment contexts.
Primidone is prescribed for some types of epilepsy and for essential tremor. Having shaking hands does not establish essential tremor or mean that primidone is the appropriate treatment. A clinician assesses the cause and management options.
If primidone is already part of your treatment, keep the reason for prescribing it and the current instructions clear when discussing the medicine. A plan for tremor and a plan for epilepsy may have different clinical considerations.
For general condition information, the NHS explains tremor assessment and epilepsy care. Your own clinician’s advice takes priority over an article.
Read the essential tremor guide →Strength and manufacturer are part of the enquiry.
Different primidone tablet strengths and manufacturers exist. The linked Aspire leaflet covers 50 mg and 250 mg tablets. This is not a complete availability list and does not mean those products are currently held by the pharmacy.
Record the strength and any product or manufacturer specified on the prescription. For a supply query, include the details on the current dispensing label rather than describing a tablet only by its appearance.
Do not combine tablet strengths or infer a new dose from a shortage. The prescription and any proposed change need professional checking.
For epilepsy, manufacturer continuity matters.
The MHRA places primidone in category 1 of its guidance on switching anti-seizure medicines between manufacturers. For epilepsy, its advice is to keep the patient on a specific manufacturer’s product.
If the usual product is unavailable, explain the manufacturer requirement to the pharmacy and prescribing team. Any exceptional change needs their clinical consideration rather than an automatic swap.
This epilepsy guidance should not be used to invent a treatment plan for tremor. Ask the relevant clinician what consistency is needed for your own prescription. Read the MHRA manufacturer-switching guidance ↗.
Read the precautions and know when to seek advice.
The leaflet describes effects including dizziness, unsteadiness and drowsiness, and important precautions about other medicines and pregnancy. It also warns against stopping treatment abruptly.
Discuss troublesome effects, increased or changed seizures, or any unclear directions with the appropriate clinician. Severe skin reactions are among the leaflet’s urgent warnings; seek immediate medical advice for a severe rash with blistering or mouth sores.
Use the leaflet supplied with your own medicine for the full information. Do not change or stop treatment on the basis of this general summary.
Keep the treatment instructions easy to follow.
A clear record can be useful if your directions have changed over time. Keep the current label, the product leaflet and any written clinician instructions together, and ask the pharmacy to resolve discrepancies.
If you find the packaging or written instructions difficult because of tremor or another practical problem, tell the pharmacist. Ask what support can be considered for your circumstances. Do not assume a different formulation or medicine pack is automatically appropriate.
For carers, explain who helps with ordering and taking medicines so the team can discuss an appropriate arrangement with the patient’s permission.
If the next prescription is not straightforward.
Ask whether the correct prescription has been issued and whether the exact product has been checked for supply. Mention the manufacturer, quantity and date the next supply is needed.
For epilepsy, contact the prescribing team promptly if a gap is likely; manufacturer consistency and the clinical plan need consideration. For tremor, ask the clinician or pharmacist for individual advice rather than copying epilepsy instructions or adjusting the dose to stretch supplies.
Annfield Plain Pharmacy’s general prescription-support guide explains the enquiry process. The branch confirms current supply and any collection or delivery arrangement for the actual prescription.
Questions patients and carers ask
Is primidone only used for epilepsy?
No. The linked patient leaflet also describes use for essential tremor. The prescribing decision and treatment instructions are individual.
Can a different manufacturer be supplied for epilepsy?
The MHRA advises maintaining primidone on a specific manufacturer’s product for epilepsy. Discuss an availability problem with the pharmacist and prescriber before any change.
Can I use a different tablet strength to make up the dose?
Do not work out a replacement supply yourself. The pharmacist and prescriber must check the prescription and any proposed change.
Does the page confirm 50 mg or 250 mg stock?
No. Those are strengths described in the linked leaflet, not a stock list. The branch checks the exact prescription item.
UK prescription questions
Understanding supply and repeat arrangements in the UK
Primidone 50 mg, 125 mg or 250 mg: identify the exact prescription
UK product information includes these tablet strengths, but a strength being listed does not establish that a particular supplier has it today. Read the full wording on your current pack and prescription, including the manufacturer or brand where specified. Have the quantity prescribed available for a pharmacy conversation. A different strength or tablet count needs a professional check; it is not a calculation to make yourself when one pack is hard to obtain.
Source: Enodama UK patient leaflet (primidone strengths), checked 12 October 2026 ↗
When your usual pharmacy cannot obtain primidone
Ask which exact product is affected, whether part of the prescription has been supplied and when the pharmacy expects its next update. An individual pharmacy's ordering difficulty and a confirmed national shortage are different pieces of information. When asking another pharmacy for help, explain the current prescription status so the teams can establish who is handling it. Do not request duplicate prescriptions from several places on the assumption that all will be needed.
A supply enquiry alongside epilepsy or essential-tremor care
The reason for the prescription matters to the clinical team, particularly when discussing continuity or any proposed change. Use the condition guidance below to prepare questions for your usual team. A website search for a different brand cannot decide whether it is suitable for you. If the remaining supply is becoming short, telephone the pharmacy or prescriber and explain the date by which advice is needed; a routine email is unsuitable for an imminent missed dose.
Planning a UK repeat or delivery enquiry
For a routine enquiry, the useful starting details are the exact product, strength, form and whether the prescription has been issued. For a delivery question, give your postcode and ask which arrangements can be offered. The branch is in England and confirms prescription acceptance, sourcing, any charges and delivery individually. Keep your existing collection or supply arrangement in place until the next step has been agreed.
Read the UK prescription and delivery guide →
This practical section was added on 12 October 2026. Availability is confirmed directly with the pharmacy for the exact product; no live stock is shown here.
Questions about your pharmacy arrangements?
Read how prescription enquiries, collection and delivery checks work. The branch confirms arrangements for the actual prescription and address.
About prescription support →Monday–Friday, 9am–6pm. Give a brief enquiry first; the branch arranges any further information needed.
Sources and further reading
- emc: Primidone Aspire patient leaflet ↗
- MHRA: switching anti-seizure medicines between manufacturers ↗
- NHS: tremor or shaking hands ↗
- NHS: epilepsy ↗
Information prepared by FindMyMeds. Sources checked on 11 October 2026. Medical-page approver: Ranjit Rana. Page-specific sign-off dates have not yet been recorded for this review build. Read the leaflet supplied with your actual medicine and ask a pharmacist or prescriber about individual questions.
How we prepare this information